KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Change in Acquisitions & Divestments: 2015-2025

Historic Change in Acquisitions & Divestments for BeOne Medicines (ONC) over the last 9 years, with Mar 2025 value amounting to $1.8 million.

  • BeOne Medicines' Change in Acquisitions & Divestments fell 32.20% to $1.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $110.2 million, marking a year-over-year decrease of 63.14%. This contributed to the annual value of $2.7 million for FY2024, which is 99.61% down from last year.
  • According to the latest figures from Q1 2025, BeOne Medicines' Change in Acquisitions & Divestments is $1.8 million, which was down 32.20% from $2.7 million recorded in Q1 2024.
  • BeOne Medicines' 5-year Change in Acquisitions & Divestments high stood at $1.1 billion for Q1 2021, and its period low was -$10,000 during Q4 2021.
  • Moreover, its 3-year median value for Change in Acquisitions & Divestments was $54.2 million (2023), whereas its average is $112.9 million.
  • As far as peak fluctuations go, BeOne Medicines' Change in Acquisitions & Divestments slumped by 100.00% in 2021, and later spiked by 2,112,300.00% in 2022.
  • Quarterly analysis of 5 years shows BeOne Medicines' Change in Acquisitions & Divestments stood at -$10,000 in 2021, then spiked by 2,112,300.00% to $211.2 million in 2022, then slumped by 49.95% to $105.7 million in 2023, then plummeted by 99.30% to $2.7 million in 2024, then plummeted by 32.20% to $1.8 million in 2025.
  • Its Change in Acquisitions & Divestments was $1.8 million in Q1 2025, compared to $2.7 million in Q1 2024 and $105.7 million in Q4 2023.